# Graph Therapeutics **Source:** https://www.startuphub.ai/startups/graph-therapeutics **Profile type:** Startup > Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis. ## About Graph Therapeutics is a next-generation techbio company focused on developing precision medicines for inflammatory and immune-mediated diseases. They leverage a proprietary 'lab-in-the-loop' AI platform that combines perturbation modeling of live patient samples, functional and multi-omics profiling, and advanced machine learning to understand immune dysfunction at scale. By analyzing real patient tissue, Graph identifies disease mechanisms, novel therapeutic targets, and biomarkers to create differentiated therapies. The company has a validated platform and is advancing an internal pipeline of therapeutics, while also exploring strategic partnerships and out-licensing opportunities. ## Key facts - **Slug:** graph-therapeutics - **Website:** https://www.graphtx.com/ - **Location:** Austria - **Founded:** 2021-01-01 - **Operating status:** Active - **Total funding:** $5M - **Sectors / tags:** Biotechnology, Artificial Intelligence, Healthcare, Drug Discovery, Precision Medicine, Biotech, AI-Driven Drug Discovery, Immunology, Inflammatory Diseases, Genomics, Multi-omics, Platform, AI Infrastructure - **Social:** - LinkedIn: https://www.linkedin.com/company/graphtx ## Frequently asked ### What does Graph Therapeutics do? Graph Therapeutics is a next-generation techbio company focused on developing precision medicines for inflammatory and immune-mediated diseases. They leverage a proprietary 'lab-in-the-loop' AI platform that combines perturbation modeling of live patient samples, functional and multi-omics profiling, and advanced machine learning to understand immune dysfunction at scale. By analyzing real patient tissue, Graph identifies disease mechanisms, novel therapeutic targets, and biomarkers to create di… ### What is Graph Therapeutics's revenue? StartupHub estimates Graph Therapeutics's annual revenue at $427K (range $149K to $2.0M, 34% confidence), based on comparable companies in the sector. ### What is Graph Therapeutics's valuation? StartupHub estimates Graph Therapeutics's effective valuation at $18.6M (range $12.5M to $30.0M, 24% confidence), based on comparable companies in the sector. ### How much funding has Graph Therapeutics raised? Graph Therapeutics has raised a total of $5M in funding. The most recent round on record is Funding Round. ### Where is Graph Therapeutics headquartered? Graph Therapeutics is headquartered in Austria. ### When was Graph Therapeutics founded? Graph Therapeutics was founded in 2021. ### What industry does Graph Therapeutics operate in? Graph Therapeutics operates in Biotechnology, Artificial Intelligence, Healthcare, Drug Discovery, Precision Medicine, Biotech. ## JSON-LD Structured data aligned with this page's `